Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. Biodel's products are created by utilizing the company's proprietary VIAdelTM technology, which enables rapid delivery of drugs into the blood through various routes of administration. Faster onset of action and non-invasive routes of delivery improve the efficacy, safety, compliance and convenience for patients.
|Jul 29, 2016
4:00 PM ET|